Effect of orexin receptor-1 agonist and antagonist microinjection into the ventral tegmental area on morphine withdrawal syndrome

mohammad hossein esmaeili; hassan Azhdarea; hashem haghdoost; mohammad sofiabadea

Journal of Inflammatory Diseases

The Official Journal of Qazvin University of Medical Sciences

Current Issue All Issues In Press Accepted Manuscripts Search

Journal Information Editors & Boards Indexing and Listing Sources Reviewer and AE Registration Form Journal Metrics Open Peer Review (OPR)Publication Ethics and Publication Malpractice Statement Support Contact Us

Authors Guide Submit Manuscript

Effect of orexin receptor-1 agonist and antagonist microinjection into the ventral tegmental area on morphine withdrawal syndrome

Author(s):

mohammad hossein esmaeili¹,

hassan Azhdarea^,*,

hashem haghdoost²,

mohammad sofiabadea²

1Qazvine univesity f medical sciences

2medical sciences

Journal of Inflammatory Diseases:Vol. 17, issue 3; 4-11

Article type:Research Article

How to Cite:mohammad hossein esmaeilihassan Azhdareahashem haghdoostmohammad sofiabadeaEffect of orexin receptor-1 agonist and antagonist microinjection into the ventral tegmental area on morphine withdrawal syndrome.J Inflamm Dis.17(3):e155763.

Abstract

Background: Several Studies have identified that the mesocorticolimbic dopaminergic pathway consisting of the ventral tegmental area (VTA) and the nucleus accumbens (NAc) plays an important role in morphine dependence and withdrawal signs . Orexin projection and its receptors have been found in the brain regions including VTA that involved in the expression of morphine withdrawal signs . Objective: The aim of this study was to evaluate the effects of orexin receptor-1 (OX1R) agonist and antagonist microinjection into the VTA on withdrawal signs in morphine dependent rats. Methods: This experimental study was carried out on 24 male Wistar rats (weighing 250-300 g) in 2012 that were divided in 4 groups. They were rendered morphine dependent by subcutaneous injection of morphine sulfate at intervals of 12 h for 10 days. On day 11, intra-VTA microinjection of orexin receptor-1 agonist (orexin-A) and antagonist (SB-334867) was performed ( 2h after last morphine injection and before naloxan injection) and naloxone precipitated withdrawal sings were evaluated for 30 min. In the vehicle group, normal salin was microinjected into the VTA. Data were analyzed using t-test and ANOVA. Findings: Intra-VTA SB-334867 microinjection significantly decreased the jumping sign (P< 0.01). Orexin-A microinjection significantly increased the wet-dog shakes sign (P< 0.05). Conclusion: With regard to the results, OX1R in the VTA has a little effect on expression of withdrawal signs in morphine dependent rats .

Keywords

Orexin

Ventral Tegmental Area (VTA)

Morphine Dependence

Substance Withdrawal Syndrome

comments